ATOSSA THERAPEUTICS, INC.

ATOS · Nasdaq · SIC 2834: Pharmaceutical Preparations
301
SEC Filings

Business Summary

5 Item 1A. Risk Factors 22 Item 1B. Unresolved Staff Comments 44 Item 1 C. Cybersecurity 44 Item 2. Properties 44 Item 3. Legal Proceedings 44 Item 4. Mine Safety Disclosures 44 PART II Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 45 Item 6. Reserved 45 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 46 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 55 It...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionATOSdiscussed_in_filing Cybersecurity
topic_mentionATOSdiscussed_in_filing Cybersecurity
topic_mentionATOSdiscussed_in_filing Cybersecurity
topic_mentionATOSdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001193125-26-124396EDGAR59K words
2025-03-252024-12-310000950170-25-044099EDGAR—
2024-04-012023-12-310000950170-24-039306EDGAR—
2023-03-222022-12-310001437749-23-007531EDGAR—
2022-02-282021-12-310001437749-22-004614EDGAR—
2021-03-312020-12-310001437749-21-007756EDGAR—
2020-03-262019-12-310001437749-20-006155EDGAR—
2019-03-282018-12-310001437749-19-005927EDGAR—
2018-03-082017-12-310001615774-18-001693EDGAR—
2017-03-162016-12-310001615774-17-001088EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-276160EDGAR35K words
2025-08-122025-06-300000950170-25-106947EDGAR—
2025-05-132025-03-310000950170-25-069827EDGAR—
2024-11-122024-09-300000950170-24-124668EDGAR—
2024-08-122024-06-300000950170-24-095102EDGAR—
2024-05-132024-03-310000950170-24-058244EDGAR—
2023-11-132023-09-300001437749-23-031424EDGAR—
2023-08-142023-06-300001437749-23-023426EDGAR—
2023-05-152023-03-310001437749-23-014366EDGAR—
2022-11-072022-09-300001437749-22-026178EDGAR—
2022-08-082022-06-300001437749-22-019359EDGAR—
2022-05-092022-03-310001437749-22-011508EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001193125-26-124393EDGAR3K words
2026-02-200001193125-26-061412EDGAR—
2026-02-170001193125-26-054797EDGAR—
2026-02-110001193125-26-045628EDGAR—
2026-01-260001193125-26-021727EDGAR—
2026-01-090001193125-26-008314EDGAR—
2026-01-060001193125-26-003506EDGAR—
2025-12-040001193125-25-307516EDGAR—
2025-11-120001193125-25-276140EDGAR—
2025-10-140001193125-25-238065EDGAR—

301 total filings indexed. 269 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001488039
TickerATOS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: add8d9f076adebc676807bbd4d326bc3aea28dce40b059d23538159a51181478
parent: e67f556b8cc44eee5d6e665ea7247e5fe0ad3de5488b87ac138ada990b3795e1
content hash: b103f68c7c2ad52d22a321e7e2c7c8a77de9efc99d37528809179fc5270d9947
signed: 2026-04-13T04:43:47.470Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf